Insider Transactions in Q4 2023 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
612
-2.73%
|
$541,008
$884.88 P/Share
|
|
Dec 28
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
850
+3.65%
|
$321,300
$378.98 P/Share
|
|
Dec 27
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
2,448
-14.55%
|
$2,095,488
$856.71 P/Share
|
|
Dec 27
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
542
-2.45%
|
$472,624
$872.21 P/Share
|
|
Dec 27
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+3.28%
|
$283,500
$378.98 P/Share
|
|
Dec 27
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
2,049
-62.17%
|
$1,840,002
$898.0 P/Share
|
|
Dec 27
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,049
+38.33%
|
$987,618
$482.68 P/Share
|
|
Dec 22
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
250
-1.46%
|
$211,500
$846.27 P/Share
|
|
Dec 21
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
1,680
-4.56%
|
$1,416,240
$843.94 P/Share
|
|
Dec 13
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
610
-32.85%
|
$530,700
$870.0 P/Share
|
|
Dec 13
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
610
+24.73%
|
$229,360
$376.69 P/Share
|
|
Dec 13
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-3.27%
|
$629,733
$871.12 P/Share
|
|
Dec 13
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.33%
|
$378,000
$378.98 P/Share
|
|
Dec 12
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
7,657
-13.68%
|
$6,554,392
$856.71 P/Share
|
|
Dec 12
2023
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
5,105
-24.97%
|
$4,369,880
$856.71 P/Share
|
|
Dec 12
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,381
-23.23%
|
$5,462,136
$856.71 P/Share
|
|
Dec 12
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,552
-11.98%
|
$2,184,512
$856.71 P/Share
|
|
Dec 11
2023
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,841
-3.32%
|
$10,837,804
$844.09 P/Share
|
|
Dec 11
2023
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,155
+6.1%
|
-
|
|
Dec 11
2023
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,841
-1.68%
|
$10,837,804
$844.09 P/Share
|
|
Dec 11
2023
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,155
+3.18%
|
-
|
|
Dec 11
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
5,774
-4.73%
|
$4,873,256
$844.09 P/Share
|
|
Dec 11
2023
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
725
-1.37%
|
$611,900
$844.09 P/Share
|
|
Dec 11
2023
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-7.0%
|
$2,718,524
$844.09 P/Share
|
|
Dec 11
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-3.4%
|
$1,296,384
$844.09 P/Share
|
|
Dec 11
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-5.34%
|
$2,718,524
$844.09 P/Share
|
|
Dec 11
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-2.18%
|
$564,636
$844.09 P/Share
|
|
Dec 11
2023
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-1.79%
|
$314,812
$844.09 P/Share
|
|
Dec 11
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
270
-1.28%
|
$226,260
$838.44 P/Share
|
|
Dec 08
2023
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
3,199
+4.93%
|
-
|
|
Dec 08
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-1.49%
|
$744,369
$843.79 P/Share
|
|
Dec 08
2023
|
Neil Stahl EVP Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
853
+1.59%
|
-
|
|
Dec 08
2023
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
809
-1.54%
|
$681,987
$843.79 P/Share
|
|
Dec 08
2023
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Grant, award, or other acquisition
|
Direct |
3,199
+11.94%
|
-
|
|
Dec 08
2023
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-5.15%
|
$934,044
$843.79 P/Share
|
|
Dec 08
2023
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+9.4%
|
-
|
|
Dec 08
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-2.26%
|
$399,582
$843.79 P/Share
|
|
Dec 08
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,013
-3.2%
|
$853,959
$843.79 P/Share
|
|
Dec 08
2023
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Grant, award, or other acquisition
|
Direct |
2,133
+6.5%
|
-
|
|
Dec 08
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
852
-2.9%
|
$718,236
$843.79 P/Share
|
|
Dec 08
2023
|
Marion Mc Court EVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
2,133
+9.19%
|
-
|
|
Dec 08
2023
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
852
-4.3%
|
$718,236
$843.79 P/Share
|
|
Dec 05
2023
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,536
-0.86%
|
$5,326,840
$816.0 P/Share
|
|
Dec 04
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
13,464
-16.95%
|
$10,946,232
$813.58 P/Share
|
|
Dec 04
2023
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.12%
|
$5,400,000
$270.43 P/Share
|
|
Dec 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$81,800
$818.55 P/Share
|
|
Nov 14
2023
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,492
-0.93%
|
$5,193,600
$800.35 P/Share
|
|
Nov 13
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
13,508
-17.01%
|
$10,738,860
$795.69 P/Share
|
|
Nov 13
2023
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.12%
|
$5,400,000
$270.43 P/Share
|
|
Nov 10
2023
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
400
-0.75%
|
-
|